Evotec SE (ETR:EVT)
Germany · Delayed Price · Currency is EUR 5.80
-0.01 (-0.24%)
At close: Nov 28, 2025
Evotec SE Revenue
Evotec SE had revenue of 163.89M EUR in the quarter ending September 30, 2025, a decrease of -11.36%. This brings the company's revenue in the last twelve months to 756.33M, down -2.67% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.
Revenue (ttm)
756.33M
Revenue Growth
-2.67%
P/S Ratio
1.36
Revenue / Employee
157.96K
Employees
4,740
Market Cap
1.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
| Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
| Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
| Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
| Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Evotec SE News
- 6 days ago - EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 17 days ago - EQS-DD: Evotec SE: Wesley Wheeler, buy - Wallstreet:Online
- 18 days ago - Evotec (EVO) Secures $5M Milestone from Bristol Myers Squibb - GuruFocus
- 18 days ago - Evotec gets $5M milestone payment from Bristol Myers after FDA accepts new drug application - Seeking Alpha
- 18 days ago - Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership - Accesswire
- 18 days ago - Evotec Hits Milestone with Bristol Myers Squibb in Protein Partnership - Wallstreet:Online
- 22 days ago - Evotec SE 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 23 days ago - EQS-CMS: Evotec SE: Release of a capital market information - Wallstreet:Online